← Capa | Mercado

AI women's health startup Evvy lands $40M Series B to scale diagnostics platform

2026-11-04 · Fonte:SiliconANGLE

AI women's health startup Evvy lands $40M Series B to scale diagnostics platform

Evvy closes a $40 million Series B led by Catalio Capital Management as it moves to scale its AI-driven precision diagnostics and care platform for women's health.

Evvy, an artificial intelligence startup focused on improving women's healthcare, has closed a $40 million Series B round to scale its precision diagnostics and care platform. The financing was led by Catalio Capital Management, with a group of new investors joining the cap table: the U.S. Fertility Innovation Fund, Rethink Impact, Muse Capital and Alumni Ventures.

The raise centers on the company's core proposition: applying artificial intelligence to precision diagnostics and medicine in women's health. Evvy's platform combines diagnostics with care delivery, and the new capital is earmarked explicitly for scaling that combined offering. By designating the financing a Series B, the startup is positioning itself beyond early-stage validation and into a growth phase in which execution on its diagnostics platform becomes the priority.

The investor lineup is a key detail. Catalio Capital Management took the lead, while the U.S. Fertility Innovation Fund, Rethink Impact, Muse Capital and Alumni Ventures all come in as new investors—a fresh slate of backers joining the company's existing shareholder base. The presence of a fund bearing the U.S. Fertility name ties the financing to the fertility ecosystem, an adjacent clinical area to the women's health diagnostics Evvy is building. The remaining new names broaden the syndicate at a stage when companies typically need larger pools of capital to scale operations.

For readers tracking venture flows into applied AI, the deal is another data point in the movement of capital toward AI-driven healthcare applications, an area where diagnostics platforms such as Evvy's sit at the intersection of clinical care and machine learning. The $40 million tranche gives the company resources to accelerate precision diagnostics and medicine for women's health—the stated aim of the round—and extends a financing pattern in which a specialist lead anchors a healthcare AI deal while a broader roster of funds comes in as new capital at the growth stage.

Tags: Evvy · Women's Health · Precision Diagnostics · Series B · Venture Capital · AI Diagnostics


Leituras relacionadas


萬安算交所 AIXX · AIXX · Exchange verificado · Ir ao mercado